The biggest test of an experimental COVID-19 vaccine began on Monday with the first round of nearly 30,000 Americans getting a shot.
The vaccine was developed by the National Institutes of Health and Moderna Inc.
“I’m excited to be part of something like this. This is huge,” said Melissa Harting, a 36-year-old nurse who received an injection in Binghamton.
Another company, Pfizer Inc., is also working on a vaccine, which will test around 30,000 people.
“We’ve been sitting on the sidelines passively attempting to wear our masks and social distance and not go out when it’s not necessary. This is the first step of becoming active against this,” said Dr. Frank Eder of Meridian Clinical Research, the company that runs the Binghamton trial site. “There’s really no other way to get past this.”
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected]